lysine has been researched along with Meningioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrew Futreal, P; Becker, A; Capper, D; Collins, VP; Eils, R; Giese, N; Hagenlocher, C; Hartmann, C; Herold-Mende, C; Jäger, N; Jones, DT; Ketter, R; Kickingereder, P; Koelsche, C; König, R; Kool, M; Kraus, J; Lenartz, D; Mawrin, C; Meyer, J; Mucha, J; Pfister, SM; Piro, RM; Pusch, S; Reuss, DE; Sahm, F; Santarius, T; Schweizer, L; Simon, M; Stephens, PJ; Tarpey, PS; von Deimling, A; Wellenreuther, R; Wiestler, OD | 1 |
| Bouterfa, H; Bushnell, D; Carlisle, T; Connolly, M; Kahn, D; Karwal, M; Madsen, M; Menda, Y; Miller, S; O'Dorisio, S; O'Dorisio, T; Ponto, J; Squires, S; Walkner, W | 1 |
1 trial(s) available for lysine and Meningioma
| Article | Year |
|---|---|
Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.
Topics: Adult; Aged; Amino Acids; Arginine; Carcinoid Tumor; Female; Humans; Infusions, Intravenous; Kidney; Lung Neoplasms; Lysine; Male; Meningioma; Middle Aged; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Yttrium Radioisotopes | 2004 |
1 other study(ies) available for lysine and Meningioma
| Article | Year |
|---|---|
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
Topics: DNA Mutational Analysis; Genomics; Glutamine; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lysine; Meningeal Neoplasms; Meningioma; Mutation; Polymorphism, Single Nucleotide; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2013 |